HIVE
Price
$3.19
Change
-$0.16 (-4.78%)
Updated
Jul 13 closing price
Capitalization
857.09M
Intraday BUY SELL Signals
STEX
Price
$0.84
Change
-$0.08 (-8.70%)
Updated
Jul 13 closing price
Capitalization
87.59M
11 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HIVE vs STEX

HIVE vs STEX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HIVE vs. STEX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIVE is a Hold and STEX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (HIVE: $3.19 vs. STEX: $0.92)
Brand notoriety: HIVE and STEX are both not notable
Both companies represent the Investment Banks/Brokers industry
Current volume relative to the 65-day Moving Average: HIVE: 22% vs. STEX: 23%
Market capitalization -- HIVE: $857.09M vs. STEX: $87.59M
HIVE [@Investment Banks/Brokers] is valued at $857.09M. STEX’s [@Investment Banks/Brokers] market capitalization is $87.59M. The market cap for tickers in the [@Investment Banks/Brokers] industry ranges from $928.5B to $0. The average market capitalization across the [@Investment Banks/Brokers] industry is $14.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HIVE’s FA Score shows that 1 FA rating(s) are green whileSTEX’s FA Score has 0 green FA rating(s).

  • HIVE’s FA Score: 1 green, 4 red.
  • STEX’s FA Score: 0 green, 5 red.
According to our system of comparison, HIVE is a better buy in the long-term than STEX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HIVE’s TA Score shows that 4 TA indicator(s) are bullish while STEX’s TA Score has 5 bullish TA indicator(s).

  • HIVE’s TA Score: 4 bullish, 7 bearish.
  • STEX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, STEX is a better buy in the short-term than HIVE.

Price Growth

HIVE (@Investment Banks/Brokers) experienced а -5.62% price change this week, while STEX (@Investment Banks/Brokers) price change was -5.47% for the same time period.

The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -7.53%. For the same industry, the average monthly price growth was -8.39%, and the average quarterly price growth was -19.38%.

Reported Earning Dates

STEX is expected to report earnings on Jul 24, 2026.

Industries' Descriptions

@Investment Banks/Brokers (-7.53% weekly)

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HIVE($857M) has a higher market cap than STEX($87.6M). HIVE YTD gains are higher at: 23.643 vs. STEX (-72.277). HIVE has higher annual earnings (EBITDA): 27.2M vs. STEX (-489.68M). HIVE has more cash in the bank: 32.9M vs. STEX (30.6M). STEX has less debt than HIVE: STEX (0) vs HIVE (71.1M). HIVE has higher revenues than STEX: HIVE (298M) vs STEX (0).
HIVESTEXHIVE / STEX
Capitalization857M87.6M978%
EBITDA27.2M-489.68M-6%
Gain YTD23.643-72.277-33%
P/E Ratio9.17N/A-
Revenue298M0-
Total Cash32.9M30.6M108%
Total Debt71.1M0-
FUNDAMENTALS RATINGS
HIVE vs STEX: Fundamental Ratings
HIVE
STEX
OUTLOOK RATING
1..100
7250
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
4184
P/E GROWTH RATING
1..100
23100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HIVE's Valuation (70) in the Computer Communications industry is in the same range as STEX (98) in the Medical Specialties industry. This means that HIVE’s stock grew similarly to STEX’s over the last 12 months.

HIVE's Profit vs Risk Rating (100) in the Computer Communications industry is in the same range as STEX (100) in the Medical Specialties industry. This means that HIVE’s stock grew similarly to STEX’s over the last 12 months.

HIVE's SMR Rating (98) in the Computer Communications industry is in the same range as STEX (100) in the Medical Specialties industry. This means that HIVE’s stock grew similarly to STEX’s over the last 12 months.

HIVE's Price Growth Rating (41) in the Computer Communications industry is somewhat better than the same rating for STEX (84) in the Medical Specialties industry. This means that HIVE’s stock grew somewhat faster than STEX’s over the last 12 months.

HIVE's P/E Growth Rating (23) in the Computer Communications industry is significantly better than the same rating for STEX (100) in the Medical Specialties industry. This means that HIVE’s stock grew significantly faster than STEX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HIVESTEX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 29 days ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HIVE
Daily Signal:
Gain/Loss:
STEX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYHCX100.68N/A
N/A
Rydex Health Care C
OILGX26.58N/A
N/A
Optimum Large Cap Growth Instl
LGASX74.87N/A
N/A
ClearBridge Small Cap FI
PWTYX56.26N/A
N/A
UBS US Allocation P
MKVHX18.88N/A
N/A
MFS International Large Cap Value R6

STEX and

Correlation & Price change

A.I.dvisor indicates that over the last year, STEX has been loosely correlated with KEEL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if STEX jumps, then KEEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STEX
1D Price
Change %
STEX100%
-8.46%
KEEL - STEX
35%
Loosely correlated
-6.24%
LMFA - STEX
28%
Poorly correlated
-96.46%
HIVE - STEX
27%
Poorly correlated
-4.78%
BTBT - STEX
27%
Poorly correlated
-2.96%
HUT - STEX
26%
Poorly correlated
-2.98%
More